BamSEC and AlphaSense Join Forces
Learn More

Structure Therapeutics Inc. – Indentures

NASDAQ: GPCR    
Share price (6/22/26): $45.51    
Market cap (6/22/26): $3.235 billion
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 11 pages Structure Therapeutics Inc. Form of Pre-Funded Warrant to Purchase Ordinary Shares Represented by American Depositary Shares
12/34/56
EX-4.10
from S-3ASR 54 pages Structure Therapeutics Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20__ Debt Securities
12/34/56
EX-4.9
from S-3ASR 17 pages Structure Therapeutics Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Structure Therapeutics Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.7
from S-3ASR 20 pages Structure Therapeutics Inc. and , as Warrant Agent Form of Preferred Shares Warrant Agreement Dated as of Structure Therapeutics Inc. Form of Preferred Shares Warrant Agreement
12/34/56
EX-4.6
from S-3ASR 20 pages Structure Therapeutics Inc. and , as Warrant Agent Form of Ordinary Shares Warrant Agreement Dated as of Structure Therapeutics Inc. Form of Ordinary Shares Warrant Agreement
12/34/56
EX-4.5
from S-1 10 pages Structure Therapeutics Inc. Form of Pre-Funded Warrant to Purchase Ordinary Shares Represented by American Depositary Shares
12/34/56
EX-4.5
from 10-Q 2 pages Summary of Rights of Non-Voting Ordinary Shares
12/34/56
EX-4.5
from 10-K 24 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.2
from S-1/A 45 pages Parties 1 Recitals 1 Section 1. Certain Definitions 1
12/34/56
EX-4.1
from S-1/A 1 page Share Capital Is US$60,000 Divided Into 600,000,000 Shares Consisting of (I) 500,000,000 Ordinary Shares of a Par Value of US$0.0001 Each; (II) 100,000,000 Undesignated Shares of a Par Value of US$0.0001 Each, of Such Class or Classes (However Designated) as the Board of Directors May Determine
12/34/56
EX-4.4
from S-1 57 pages Second Amended and Restated Investor Rights Agreement
12/34/56
EX-4.4
from DRS 57 pages Second Amended and Restated Investor Rights Agreement
12/34/56